Key result
Extracorporeal shock-wave therapy provided no added benefit over sham treatment for rotator cuff tendonitis, with mean SPADI score changes of 28.4 vs 30.4 at 6 months.
Why the study?
Does extracorporeal shock-wave therapy improve pain and disability in adults with chronic non-calcific tendonitis of the rotator cuff?
Population
74 adults with chronic non-calcific tendonitis of the rotator cuff
Comparison
Extracorporeal shock-wave therapy, monthly for… vs Sham treatment, monthly for three months
Design
RCT, randomised, double-blind, placebo-controlled
Follow-up
6 months
Authors
Loading...
ESWT should not be used for chronic non-calcific rotator cuff tendonitis; confirms no added benefit over sham in this RCT.
RCT (n=74)
Double-blind
Does extracorporeal shock-wave therapy improve pain and disability in adults with chronic non-calcific tendonitis of the rotator cuff?
Absolute Event Rate: 28.4% vs 30.4%
Moderate doses of extracorporeal shock-wave therapy provide no added benefit over sham treatment for chronic non-calcific tendonitis of the rotator cuff.
Speed et al. (2002) conducted an RCT in Non-calcific tendonitis of the rotator cuff (n=74). Extracorporeal shock-wave therapy (ESWT) vs. Sham treatment was evaluated on Change in the Shoulder Pain and Disability Index (SPADI) scores and night pain. Extracorporeal shock-wave therapy provided no added benefit over sham treatment for rotator cuff tendonitis, with mean SPADI score changes of 28.4 vs 30.4 at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: